Mutations in BAP1 were first identified in studies of familial malignancies, which manifested as increased prevalence of rare malignancies in some families, such as malignant mesothelioma, cutaneous melanoma, and uveal melanoma (32). This evidence concerns the gene BAP1 and uveal melanoma.